Literature DB >> 11253987

Chagas' disease.

E S Umezawa1, A M Stolf, C E Corbett, M A Shikanai-Yasuda.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11253987     DOI： 10.1016/S0140-6736(00)04174-X

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  10 in total

1.  Arboprotozoae.

Authors: 
Journal:  Transfus Med Hemother       Date:  2009       Impact factor: 3.747

2.  The enigmatic role of cholinergic reflex in the pathogenesis of Chagas disease.

Authors:  Luiz G F de A B D'Elia Zanella; Agnaldo Bruno Chies; Maria Angélica Spadella; Altino Luiz Silva Therezo; Patrícia de Souza Rossignoli; Fernando Frei; Luciamáre Perinetti Alves Martins
Journal:  Parasitol Res       Date:  2014-04-01       Impact factor: 2.289

3.  Are increased frequency of macrophage-like and natural killer (NK) cells, together with high levels of NKT and CD4+CD25high T cells balancing activated CD8+ T cells, the key to control Chagas' disease morbidity?

Authors:  D M Vitelli-Avelar; R Sathler-Avelar; R L Massara; J D Borges; P S Lage; M Lana; A Teixeira-Carvalho; J C P Dias; S M Elói-Santos; O A Martins-Filho
Journal:  Clin Exp Immunol       Date:  2006-07       Impact factor: 4.330

Review 4.  Immunity and immune modulation in Trypanosoma cruzi infection.

Authors:  Fabíola Cardillo; Rosa Teixeira de Pinho; Paulo Renato Zuquim Antas; José Mengel
Journal:  Pathog Dis       Date:  2015-10-04       Impact factor: 3.166

5.  Uptake of host cell transforming growth factor-beta by Trypanosoma cruzi amastigotes in cardiomyocytes: potential role in parasite cycle completion.

Authors:  Mariana C Waghabi; Michelle Keramidas; Sabine Bailly; Wim Degrave; Leila Mendonça-Lima; Maria de Nazaré C Soeiro; Maria de Nazareth L Meirelles; Sidnei Paciornik; Tania C Araújo-Jorge; Jean-Jacques Feige
Journal:  Am J Pathol       Date:  2005-10       Impact factor: 4.307

6.  Risk progression to chronic Chagas cardiomyopathy: influence of male sex and of parasitaemia detected by polymerase chain reaction.

Authors:  A L Basquiera; A Sembaj; A M Aguerri; M Omelianiuk; S Guzmán; J Moreno Barral; T F Caeiro; R J Madoery; O A Salomone
Journal:  Heart       Date:  2003-10       Impact factor: 5.994

7.  Short treatment with the tumour necrosis factor-alpha blocker infliximab diminishes chronic chagasic myocarditis in rats without evidence of Trypanosoma cruzi reactivation.

Authors:  A R Pérez; G H Fontanella; A L Nocito; S Revelli; O A Bottasso
Journal:  Clin Exp Immunol       Date:  2009-08       Impact factor: 4.330

8.  Chronic Chagas' Disease: Targeting the Interleukin-2 Axis and Regulatory T Cells in a Condition for Which There Is No Treatment.

Authors:  Jose Mengel; Fabíola Cardillo; Lain Pontes-de-Carvalho
Journal:  Front Microbiol       Date:  2016-05-13       Impact factor: 5.640

9.  Role of T. cruzi exposure in the pattern of T cell cytokines among chronically infected HIV and Chagas disease patients.

Authors:  Tania Regina Tozetto-Mendoza; Dewton de Moraes Vasconcelos; Karim Yaqub Ibrahim; Ana Marli Christovam Sartori; Rita C Bezerra; Vera Lúcia Teixeira de Freitas; Maria Aparecida Shikanai-Yasuda
Journal:  Clinics (Sao Paulo)       Date:  2017-11       Impact factor: 2.365

10.  The Blockade of Interleukin-2 During the Acute Phase of Trypanosoma cruzi Infection Reveals Its Dominant Regulatory Role.

Authors:  Jorge Nihei; Fabiola Cardillo; Jose Mengel
Journal:  Front Cell Infect Microbiol       Date:  2021-11-17       Impact factor: 5.293
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.